**Pee Safe Secures $32 Million to Boost Growth and Market Presence**
Pee Safe, a leading personal hygiene brand, has announced plans to enhance its offline and online presence following a successful fundraising round of $32 million (₹290 crore) led by OrbiMed Asia Partners, a global healthcare-focused private equity firm, along with existing investors. The Series C funding round included both primary and secondary shares, as stated by the company.
The newly acquired capital will be utilized to expand Pee Safe’s retail footprint, bolster brand-led marketing efforts, and enhance its presence in quick commerce and online marketplaces. While the company did not disclose the specific amount of fresh capital raised, it highlighted its commitment to growth.
Pee Safe offers a diverse portfolio of products that cater to toilet hygiene, feminine and intimate hygiene, personal care, grooming, and wellness. Its products are available in 50,000 retail outlets across 100 cities and on major e-commerce and quick commerce platforms.
Founder Vikas Bagaria emphasized the brand’s mission to address the underserved women’s health category and challenge societal taboos. He stated, “Our focus has translated into a business built on strong fundamentals, and our ability to scale profitably reflects a disciplined, long-term approach. Partnering with OrbiMed, who share our conviction in the consumer healthcare opportunity, marks an important step in Pee Safe’s next phase.”
The company has achieved significant growth, reporting an annualized net revenue exceeding ₹150 crore. In FY25, Pee Safe generated ₹82 crore in revenue from operations, a 46% increase from ₹56 crore the previous year, while narrowing its losses to ₹4 crore.
Before this funding round, Pee Safe had raised a total of $16.5 million, with Alkemi Growth Capital as its lead investor. In 2023, the company secured an additional $3 million from investors led by Natco Pharma and Rainmatter Health.
As part of this investment, OrbiMed’s senior managing director Sunny Sharma and executive director Sumona Chakraborty will join Pee Safe’s board. OrbiMed manages approximately $20 billion in investments across public and private companies globally, with a presence in key healthcare hubs. The firm has previously invested in various health and wellness brands, including ayurvedic wellness brand Kapiva and medtech firm Innvolution Healthcare.
In conclusion, Pee Safe’s recent funding marks a pivotal moment in its growth trajectory, positioning the brand for further expansion in the personal hygiene market.
**FAQ**
**What is Pee Safe’s primary focus?**
Pee Safe primarily focuses on women’s health and personal hygiene, offering a range of products designed to address toilet hygiene, feminine hygiene, and overall wellness.
